CCL2 and neoplasm: While N1 marker expression remained stable, Neu2 (differentiation end) exhibited mild up-regulation of N2-associated markers, including ARG1, VEGFA, and CCL2 (Figure 1M), consistent with an immunosuppressive, tumor-promoting phenotype.